Further mutations of genes within the BMPR2 pathway may lead to PAH manifestation [8] for example in the co-receptors ACVRL1 and ENG. Through the advent of new sequencing technologies, such as the next generation sequencing (NGS) the sequencing of entire exomes became feasible. The gene discussed is ACVRL1; the disease is pulmonary arterial hypertension.